Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the Insulin Resistance Atherosclerosis Study

Diabetes

Volumn 51, Issue 4, 2002, Pages 1263-1270

  Hanley, Anthony J G ^a,b   D'Agostino Jr , Ralph ^c   Wagenknecht, Lynne E ^c   Saad, Mohammed F ^d   Savage, Peter J ^e   Bergman, Richard ^d   Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; PROINSULIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET DISEASE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036230490     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1263     Document Type: Article

References (57)

1. Insulin resistance versus insulin deficiency in non-insulin dependent diabetes mellitus: Problems and prospects
2. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
3. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion
4. A comparison of four methods for assessing in vivo Β-cell function in normal, obese and non-insulin-dependent diabetic man
5. Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose
6. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
7. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
8. Natural history of impaired glucose tolerance: Follow-up at Joslin Clinic
9. A prospective analysis of the HOMA model: The Mexico City Diabetes Study
10. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function
11. Hyperproinsulinaemia and amyloid in NIDDM: Clues to the etiology of islet beta cell function?
12. Proinsulin and specific insulin concentrations in high and low risk populations for NIDDM
13. Hyperinsulinemia in nondiabetic Asian subjects using specific assays for insulin, intact proinsulin, and des-31,32-proinsulin
14. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes
15. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican American subjects
16. Effects of genetic predisposition on proinsulin responses in Asian Indians
17. A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance
18. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: The Hoorn Study
19. Serum proinsulin levels are disproportionately increased in early prediabetic subjects
20. Proinsulin levels predict the development of non-insulin dependent diabetes mellitus (NIDDM) in Japanese-American men
21. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: The Mexico City Diabetes Study
22. Risk factors for the development of NIDDM in Yonchon County, Korea
23. Fasting proinsulin concentrations predict the development of type 2 diabetes
24. The relation of proinsulin, insulin and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects
25. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: The Insulin Resistance Atherosclerosis Study
26. The Insulin Resistance Atherosclerosis Study: Design, objectives and recruitment results
27. Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study
28. Assessment of insulin sensitivity in vivo
29. Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects
30. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: Suitability for use in population studies
31. MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
32. A comparison of the repeatability of insulin sensitivity with other cardiovascular disease risk factors
33. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance
34. A single threshold value of waist girth identifies normal weight and overweight subjects with excess visceral adipose tissue
35. Coated charcoal immunoassay of insulin
36. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65,66 split and 32,33 split proinsulins
37. Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study
38. Spurious correlation and the fallacy of the ratio standard revisited
39. Statistical considerations regarding the use of ratios to adjust data
40. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
41. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
42. Release of incompletely processed proinsulin is the cause of disproportionate proinsulinemia of NIDDM
43. Pathophysiology of insulin secretion in diabetes mellitus
44. Measurement of insulin and proinsulin
45. Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: Identification of a mutation by restriction enzyme mapping
46. Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozocin-administered baboons
47. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications
48. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment of adipocyte-beta cell relationships
49. Role of nitric oxide in obesity-induced beta-cell disease
50. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
51. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: Relation to plasma triglyceride and apolipoprotein B concentrations
52. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris Prospective Study
53. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM
54. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes
55. The STOP-NIDDM Trial: An international study on the efficacy of an alphaglucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
56. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance